641 related articles for article (PubMed ID: 20305648)
1. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.
Fuhrmann M; Bittner T; Jung CK; Burgold S; Page RM; Mitteregger G; Haass C; LaFerla FM; Kretzschmar H; Herms J
Nat Neurosci; 2010 Apr; 13(4):411-3. PubMed ID: 20305648
[TBL] [Abstract][Full Text] [Related]
2. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
Front Immunol; 2019; 10():2780. PubMed ID: 31849963
[TBL] [Abstract][Full Text] [Related]
4. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.
Liu Z; Condello C; Schain A; Harb R; Grutzendler J
J Neurosci; 2010 Dec; 30(50):17091-101. PubMed ID: 21159979
[TBL] [Abstract][Full Text] [Related]
5. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.
Cho SH; Sun B; Zhou Y; Kauppinen TM; Halabisky B; Wes P; Ransohoff RM; Gan L
J Biol Chem; 2011 Sep; 286(37):32713-22. PubMed ID: 21771791
[TBL] [Abstract][Full Text] [Related]
6. Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity.
Dworzak J; Renvoisé B; Habchi J; Yates EV; Combadière C; Knowles TP; Dobson CM; Blackstone C; Paulsen O; Murphy PM
PLoS One; 2015; 10(6):e0127730. PubMed ID: 26038823
[TBL] [Abstract][Full Text] [Related]
7. CX
van der Maten G; Henck V; Wieloch T; Ruscher K
BMC Neurosci; 2017 Jan; 18(1):11. PubMed ID: 28061814
[TBL] [Abstract][Full Text] [Related]
8. Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice.
Mattison HA; Nie H; Gao H; Zhou H; Hong JS; Zhang J
J Neuroimmunol; 2013 Apr; 257(1-2):110-5. PubMed ID: 23499256
[TBL] [Abstract][Full Text] [Related]
9. LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways.
Ma B; Xu L; Pan X; Sun L; Ding J; Xie C; Koliatsos VE; Cai H
Hum Mol Genet; 2016 Aug; 25(16):3515-3523. PubMed ID: 27378696
[TBL] [Abstract][Full Text] [Related]
10. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
11. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
12. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice.
Striebel JF; Race B; Carroll JA; Phillips K; Chesebro B
J Gen Virol; 2016 Jun; 97(6):1481-1487. PubMed ID: 26935332
[TBL] [Abstract][Full Text] [Related]
13. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
14.
Gyoneva S; Hosur R; Gosselin D; Zhang B; Ouyang Z; Cotleur AC; Peterson M; Allaire N; Challa R; Cullen P; Roberts C; Miao K; Reynolds TL; Glass CK; Burkly L; Ransohoff RM
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31792059
[TBL] [Abstract][Full Text] [Related]
15. Microglial Cx3cr1 knockout reduces prion disease incubation time in mice.
Grizenkova J; Akhtar S; Brandner S; Collinge J; Lloyd SE
BMC Neurosci; 2014 Mar; 15():44. PubMed ID: 24655482
[TBL] [Abstract][Full Text] [Related]
16. Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.
Steffen J; Stenzel J; Ibrahim S; Pahnke J
J Alzheimers Dis; 2018; 65(2):465-474. PubMed ID: 30040730
[TBL] [Abstract][Full Text] [Related]
17. Absence of CX3CR1 impairs the internalization of Tau by microglia.
Bolós M; Llorens-Martín M; Perea JR; Jurado-Arjona J; Rábano A; Hernández F; Avila J
Mol Neurodegener; 2017 Aug; 12(1):59. PubMed ID: 28810892
[TBL] [Abstract][Full Text] [Related]
18. Experience-Dependent Synaptic Plasticity in V1 Occurs without Microglial CX3CR1.
Schecter RW; Maher EE; Welsh CA; Stevens B; Erisir A; Bear MF
J Neurosci; 2017 Nov; 37(44):10541-10553. PubMed ID: 28951447
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.
Fonseca MI; Chu SH; Hernandez MX; Fang MJ; Modarresi L; Selvan P; MacGregor GR; Tenner AJ
J Neuroinflammation; 2017 Mar; 14(1):48. PubMed ID: 28264694
[TBL] [Abstract][Full Text] [Related]
20. Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer's Disease.
Romero-Molina C; Navarro V; Jimenez S; Muñoz-Castro C; Sanchez-Mico MV; Gutierrez A; Vitorica J; Vizuete M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
